마우스 모델 시장 분석 및 예측(-2035년) : 유형별, 제품 유형별, 서비스별, 기술별, 용도별, 구성 요소별, 최종 사용자별, 기능별, 디바이스별

Mice Model Market is anticipated to expand from $1.5 billion in 2024 to $4.0 billion by 2034, growing at a CAGR of approximately 9.5%. The Mice Model Market encompasses the development and utilization of genetically engineered mice for biomedical research, focusing on disease modeling, drug discovery, and safety testing. These models provide critical insights into human diseases, enabling advancements in personalized medicine and therapeutic interventions. With the rise in chronic diseases and demand for innovative treatments, the market is poised for significant growth, driven by technological advancements in gene editing and increasing investment in R&D.

The Mice Model Market is experiencing robust growth, fueled by advancements in genetic engineering and increasing demand for preclinical research. Genetically modified mice dominate the market, with knockout and transgenic mice being top-performing sub-segments, due to their utility in disease modeling and drug discovery. Inbred mice follow as the second highest performing segment, valued for their genetic consistency and reliability in research studies. The services segment, including breeding and cryopreservation, is gaining momentum, supporting the expanding use of customized models. Rising interest in humanized mice models is notable, driven by their potential to enhance translational research outcomes. Furthermore, the market is witnessing a shift towards advanced phenotyping technologies, improving data accuracy and research efficiency. As personalized medicine and targeted therapies continue to evolve, the demand for specialized mouse models is expected to rise, presenting lucrative opportunities for market participants. The emphasis on ethical research practices and regulatory compliance remains critical to sustainable growth.

In the Mice Model Market, market share is largely dominated by a few key players, with pricing strategies reflecting the high demand for specialized models. Recent product launches have focused on advanced genetic modifications, catering to the growing need for precision in research applications. The emphasis on innovation is evident, as companies strive to differentiate through unique offerings and enhanced capabilities. This competitive landscape is further fueled by the increasing utilization of mice models in drug development and biomedical research. Competition benchmarking reveals a dynamic environment where leading firms are constantly evolving to maintain their edge. Regulatory influences, particularly in North America and Europe, play a pivotal role in shaping market dynamics, setting stringent standards for ethical use and breeding practices. These regulations impact the operational strategies of market participants, driving compliance and innovation. The market is characterized by a robust pipeline of research initiatives, indicating a healthy trajectory of growth and opportunity for stakeholders.

Geographical Overview:

The Mice Model Market is witnessing diverse growth patterns across various regions, each presenting unique opportunities. North America leads the market, driven by advanced research facilities and substantial funding in biomedical research. The region's robust infrastructure for genetic engineering and translational research further propels its dominance. Europe follows, with strong governmental support for healthcare research and increasing demand for personalized medicine. Asia Pacific is experiencing rapid growth, fueled by rising investments in biotechnology and expanding pharmaceutical industries. The region's focus on innovative research and development enhances its market potential. Within this landscape, China and India are emerging as key players, leveraging their vast pools of scientific talent and government initiatives. Latin America and the Middle East & Africa are also gaining traction. In Latin America, growing interest in biopharmaceutical research is evident, while the Middle East & Africa are recognizing the importance of advanced research models to boost healthcare innovation.

The global tariff landscape and geopolitical risks are significantly influencing the Mice Model Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are pivoting towards enhancing domestic research capabilities to mitigate tariff-induced cost pressures on imported laboratory models. China's strategic focus is on self-sufficiency in biomedical research tools amid trade tensions, while Taiwan leverages its advanced biotech sector to maintain competitive advantage. The global market for mice models is thriving, driven by rising demand in biomedical research and drug development. By 2035, the market is poised for robust growth, contingent on geopolitical stability and innovation in genetic engineering. Middle East conflicts could disrupt global supply chains and elevate energy prices, indirectly affecting operational costs and research timelines in this sector.

Key Trends and Drivers:

The Mice Model Market is experiencing robust growth driven by advancements in genetic engineering and increased research in oncology and immunology. A key trend is the development of humanized mice models, which are pivotal for studying human-specific diseases and drug responses. These models are becoming essential tools in translational research, bridging the gap between laboratory findings and clinical applications. The demand for personalized medicine is another significant driver, pushing the need for tailor-made mice models that mimic individual genetic profiles. This trend is accelerating research in precision medicine, enabling more targeted and effective therapeutic interventions. Additionally, the rise of contract research organizations (CROs) is facilitating access to sophisticated mice models for smaller biotech firms, democratizing research capabilities. Moreover, ethical considerations and regulatory frameworks are shaping the market landscape, encouraging the development of alternative methods and refinement of existing models. Opportunities abound in emerging markets where research infrastructure is expanding, and investments in biomedical research are increasing. Companies that innovate in model creation and offer comprehensive support services are well-positioned to capture a significant share of this evolving market.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by Component
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Functionality
• 2.9 Key Market Highlights by Device

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Inbred Mice
  • 4.1.2 Genetically Engineered Mice
  • 4.1.3 Conditioned Mice
  • 4.1.4 Outbred Mice
  • 4.1.5 Hybrid Mice
  • 4.1.6 Spontaneous Mutant Mice
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Mouse Models
  • 4.2.2 Mouse Embryos
  • 4.2.3 Mouse Services
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Breeding Services
  • 4.3.2 Cryopreservation
  • 4.3.3 Quarantine Services
  • 4.3.4 Genetic Testing
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 CRISPR/Cas9
  • 4.4.2 TALENs
  • 4.4.3 Zinc Finger Nucleases
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Oncology
  • 4.5.2 Cardiovascular Studies
  • 4.5.3 Neuroscience
  • 4.5.4 Immunology
  • 4.5.5 Infectious Diseases
  • 4.5.6 Diabetes Research
• 4.6 Market Size & Forecast by Component (2020-2035)
  • 4.6.1 Live Mice
  • 4.6.2 Frozen Embryos
  • 4.6.3 Tissue Samples
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Pharmaceutical Companies
  • 4.7.2 Biotechnology Firms
  • 4.7.3 Research Institutes
  • 4.7.4 Contract Research Organizations
• 4.8 Market Size & Forecast by Functionality (2020-2035)
  • 4.8.1 Gene Expression
  • 4.8.2 Phenotypic Analysis
  • 4.8.3 Behavioral Analysis
• 4.9 Market Size & Forecast by Device (2020-2035)
  • 4.9.1 Cages
  • 4.9.2 Feeding Systems
  • 4.9.3 Monitoring Equipment

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 Component
    • 5.2.1.7 End User
    • 5.2.1.8 Functionality
    • 5.2.1.9 Device
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 Component
    • 5.2.2.7 End User
    • 5.2.2.8 Functionality
    • 5.2.2.9 Device
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 Component
    • 5.2.3.7 End User
    • 5.2.3.8 Functionality
    • 5.2.3.9 Device
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 Component
    • 5.3.1.7 End User
    • 5.3.1.8 Functionality
    • 5.3.1.9 Device
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 Component
    • 5.3.2.7 End User
    • 5.3.2.8 Functionality
    • 5.3.2.9 Device
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 Component
    • 5.3.3.7 End User
    • 5.3.3.8 Functionality
    • 5.3.3.9 Device
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 Component
    • 5.4.1.7 End User
    • 5.4.1.8 Functionality
    • 5.4.1.9 Device
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 Component
    • 5.4.2.7 End User
    • 5.4.2.8 Functionality
    • 5.4.2.9 Device
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 Component
    • 5.4.3.7 End User
    • 5.4.3.8 Functionality
    • 5.4.3.9 Device
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 Component
    • 5.4.4.7 End User
    • 5.4.4.8 Functionality
    • 5.4.4.9 Device
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 Component
    • 5.4.5.7 End User
    • 5.4.5.8 Functionality
    • 5.4.5.9 Device
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 Component
    • 5.4.6.7 End User
    • 5.4.6.8 Functionality
    • 5.4.6.9 Device
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 Component
    • 5.4.7.7 End User
    • 5.4.7.8 Functionality
    • 5.4.7.9 Device
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 Component
    • 5.5.1.7 End User
    • 5.5.1.8 Functionality
    • 5.5.1.9 Device
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 Component
    • 5.5.2.7 End User
    • 5.5.2.8 Functionality
    • 5.5.2.9 Device
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 Component
    • 5.5.3.7 End User
    • 5.5.3.8 Functionality
    • 5.5.3.9 Device
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 Component
    • 5.5.4.7 End User
    • 5.5.4.8 Functionality
    • 5.5.4.9 Device
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 Component
    • 5.5.5.7 End User
    • 5.5.5.8 Functionality
    • 5.5.5.9 Device
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 Component
    • 5.5.6.7 End User
    • 5.5.6.8 Functionality
    • 5.5.6.9 Device
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 Component
    • 5.6.1.7 End User
    • 5.6.1.8 Functionality
    • 5.6.1.9 Device
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 Component
    • 5.6.2.7 End User
    • 5.6.2.8 Functionality
    • 5.6.2.9 Device
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 Component
    • 5.6.3.7 End User
    • 5.6.3.8 Functionality
    • 5.6.3.9 Device
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 Component
    • 5.6.4.7 End User
    • 5.6.4.8 Functionality
    • 5.6.4.9 Device
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 Component
    • 5.6.5.7 End User
    • 5.6.5.8 Functionality
    • 5.6.5.9 Device

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 The Jackson Laboratory
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Taconic Biosciences
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Charles River Laboratories
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Envigo
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Janvier Labs
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Gen Oway
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Harlan Laboratories
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Horizon Discovery
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Ingenious Targeting Laboratory
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Cyagen Biosciences
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Trans Genic
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Phoenix Bio
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Crown Bioscience
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Ozgene
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Biocytogen
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Shanghai Model Organisms
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Gem Pharmatech
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Vitalstar Biotechnology
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 In Vivos
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Yecuris
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us